Cargando…
Do drugs offering only PFS maintain quality of life sufficiently from a patient’s perspective? Results from AVALPROFS (Assessing the ‘VALue’ to patients of PROgression Free Survival) study
PURPOSE: Trials of novel drugs used in advanced disease often show only progression-free survival or modest overall survival benefits. Hypothetical studies suggest that stabilisation of metastatic disease and/or symptom burden are worth treatment-related side effects. We examined this premise contem...
Autores principales: | Jenkins, V., Farewell, V., May, S., Catt, S., Matthews, L., Shilling, V., Dickson, J., Simcock, R., Fallowfield, L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6182366/ https://www.ncbi.nlm.nih.gov/pubmed/29845422 http://dx.doi.org/10.1007/s00520-018-4273-3 |
Ejemplares similares
-
IMPARTER, Phase 1 of an intervention to improve patients’ understanding of gene expression profiling tests in breast cancer
por: Fallowfield, L. J., et al.
Publicado: (2022) -
Using patient perspectives to inform communication training materials for health care professionals discussing BRCA mutation testing
por: Shilling, Valerie, et al.
Publicado: (2020) -
Talking about risk in the context of genomic tests (TARGET): development and evaluation of an educational program for clinicians
por: Fallowfield, L., et al.
Publicado: (2019) -
Patient-reported outcome measures of the impact of cancer on patients’ everyday lives: a systematic review
por: Catt, Susan, et al.
Publicado: (2016) -
A structured review of quality of life in advanced and high‐risk cutaneous squamous cell carcinoma shows the need for more studies and better measures
por: Starkings, R., et al.
Publicado: (2021)